Share ownership Medpace Holdings, Inc.

MEDP

US58506Q1094

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 11:03:19 2025-12-12 EST			5-day change	1st Jan Change
563.10 ^USD	-0.54%		+3.12%	+70.13%

12-03	Medpace Holdings Insider Sold Shares Worth $17,114,847, According to a Recent SEC Filing	MT
12-01	Medpace Holdings Insider Sold Shares Worth $34,074,470, According to a Recent SEC Filing	MT

Share class: Medpace Holdings, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	30,536,879	25,555,314 ( 83.69 %)	70,073 ( 0.2295 %)	83.69 %

Major shareholders: Medpace Holdings, Inc.

Name	Equities	%	Valuation
August Troendle 19.1 %	5,379,203	19.1 %	3 187 M $
Vanguard Fiduciary Trust Co. 8.105 %	2,282,972	8.105 %	1 353 M $
BlackRock Advisors LLC 7.816 %	2,201,556	7.816 %	1 304 M $
AQR Capital Management LLC 3.64 %	1,025,410	3.64 %	608 M $
Wasatch Advisors LP 3.287 %	925,963	3.287 %	549 M $
STATE STREET CORPORATION 2.39 %	673,141	2.39 %	399 M $
Mawer Investment Management Ltd. 2.296 %	646,774	2.296 %	383 M $
Geode Capital Management LLC 2.282 %	642,673	2.282 %	381 M $
D.E. Shaw & Co., Inc. 2.131 %	600,140	2.131 %	356 M $
Baillie Gifford & Co. 2.076 %	584,796	2.076 %	346 M $
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	75.8%
Individuals	19.54%
Other	8.18%
State Street Corp.	2.39%
SEI Investments Co.	0.34%
Swedbank AB	0.21%
Schweizerische Nationalbank	0.17%
Governments	0.08%
Manulife Financial Corp.	0.06%
Harel Insurance Investments & Financial Services Ltd.	0.04%
Hancock Whitney Corp.	0.04%
Skandinaviska Enskilda Banken AB	0.03%
Zions Bancorporation NA	0.02%
Danske Bank A/S	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	69.79%
Individuals	19.54%
United Kingdom	6.98%
Canada	5.09%
Australia	1.36%
Norway	0.77%
Switzerland	0.77%
Sweden	0.47%
Germany	0.44%
France	0.4%
Denmark	0.32%
Luxembourg	0.26%
Japan	0.22%
Ireland	0.16%
Netherlands	0.08%
Finland	0.05%
Israel	0.04%
Puerto Rico	0.04%
Singapore	0.03%
Austria	0.02%
Belgium	0.02%
China	0.02%
Spain	0.02%
South Africa	0.01%
Slovenia	0.01%

Based on 1000 largest holdings

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Employees

6,200

Sector

Biotechnology & Medical Research

Calendar

02-15 - Q4 2025 Earnings Release (Projected)

More about the company